CX PRECISION MEDICINE

Cx Precision Medicine is a life science company developing blood-based biomarker screening technology as well as companion diagnostics for therapeutic agents... Cx Precision Medicine is focusing right now on Alzheimer's disease and Parkinson's to develop a novel plan that can simplify the diagnosis and treatment of these diseases. By taking the approach that Alzheimer's, Parkinson's and other dementia-causing disorders reflect many different pathologies, treatment can be targeted more precisely... Cx Precision Medicine's technology is licensed from the University of North Texas Health Science Center (UNTHSC) laboratory of Sid O'Bryant, Ph. D., one of the world's leading experts in blood-based biomarkers for Alzheimer's disease and other neurodegenerative diseases. Dr. O'Bryant is the founder of the company and Professor of Pharmacology and Neuroscience at UNTHSC.

Primary location: Fort Worth United States